Theralase Technologies Inc. TLTFF

Primary Symbol: V.TLT

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Potential US election impact on the FDA?

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Nov 07, 2024 7:24pm

175 Views

Post# 36302194

RE:RE:RE:RE:RE:Potential US election impact on the FDA?

RFK Jr. has talked about stopping big pharma from flooding the airwaves with commercials pushing their drugs that have 20 side effects. I know there's more to it than that but I don't think there is a push to prevent life saving treatments and drugs from coming to market. Especially ones with the safety profile of Ruvidar, people need to relax.

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand